Oncology: Basic & Translational -> Basic Science (O) 405

405 - PET imaging CCR2 in Pancreatic ductal adenocarcinoma (ID 62)

Session Name
Basic Oncology & Translational IV
Speakers
Authors
Presentation Topic
Oncology: Basic & Translational -> Basic Science (O)
Presentation Number
405

Previous Eposter
403 - Preliminary evaluation of a broad-scope tumor targeting alkylphosphocholine chelate in canines with spontaneous tumors. (ID 64)

Next Eposters
407 - [18F]-FMISO PET imaging of tumor hypoxia to predict and monitor response to checkpoint inhibitor therapy. (ID 68)
408 - Preclinical Evaluation of 89Zr-Df-IAB22M2C PET as a Potential Imaging Biomarker in Targeted Immuno-Therapeutic Drug Development of a GUCY2C-CD3 bispecific antibody PF-07062119. (ID 69)
409 - [18F]-Labeled PARP-1 PET Imaging of PSMA Targeted Alpha Particle Radiotherapy Response (ID 65)
411 - Quantitative 177Lu-SPECT (QSPECT) during second cycle predicts 68Ga-octreotate-PET/CT molecular response to 177Lu-octreotate PRRT (ID 289)
413 - Toxicity and Efficacy of Multiple Cycles of An Evans Blue-Modified177Lu-labeled Octreotate at Escalating Doses in Patients with Advanced Neuroendocrine Tumors (ID 292)
414 - First-in-human study of a novel SSTR antagonist177Lu-DOTA-LM3 for peptide receptor radionuclide therapy in patients with advanced metastatic NENs and low SSTR agonist binging (ID 290)
415 - First-in-Human dose escalation of AlphaMedixTM for Targeted Alpha-Emitter Therapy of NETs (ID 288)
418 - Mixed model time-activity fitting to reduce SPECT/CT imaging time points for dosimetry in Lu-177 peptide receptor radionuclide therapy (PRRT) (ID 293)
419 - Experience with Esophago-Gastro-Intestinal Transit Scintigraphy in 229 patients: Multiple Regions of Dysmotility are Common (ID 182)
421 - Sincalide-stimulated cholescintigraphy: A retrospective study and proposal of a modified workflow. (ID 183)